|Helicobacter pylori: a poor man's gut pathogen?|
MM Khalifa, RR Sharaf, RK Aziz
Gut pathogens 2 (1), 1-12, 2010
|Mechanisms and therapeutic implications of hypermutation in gliomas|
M Touat, YY Li, AN Boynton, LF Spurr, JB Iorgulescu, CL Bohrson, ...
Nature 580 (7804), 517-523, 2020
|Contaminated water as a source of Helicobacter pylori infection: A review|
RK Aziz, MM Khalifa, RR Sharaf
Journal of advanced research 6 (4), 539-547, 2015
|Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy|
KB Einkauf, GQ Lee, C Gao, R Sharaf, X Sun, S Hua, SMY Chen, C Jiang, ...
The Journal of clinical investigation 129 (3), 988-998, 2019
|The control of HIV after antiretroviral medication pause (CHAMP) study: posttreatment controllers identified from 14 clinical studies|
G Namazi, JM Fajnzylber, E Aga, RJ Bosch, EP Acosta, R Sharaf, ...
The Journal of infectious diseases 218 (12), 1954-1963, 2018
|HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers|
R Sharaf, GQ Lee, X Sun, B Etemad, LM Aboukhater, Z Hu, ZL Brumme, ...
The Journal of clinical investigation 128 (9), 4074-4085, 2018
|Peripheral blood–derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency|
M Schmueck-Henneresse, R Sharaf, K Vogt, BJD Weist, ...
The Journal of Immunology 194 (11), 5559-5567, 2015
|The alphabet soup of HIV reservoir markers|
RR Sharaf, JZ Li
Current Hiv/aids Reports 14 (2), 72-81, 2017
|Effect of short-term antiretroviral therapy interruption on levels of integrated HIV DNA|
Z Strongin, R Sharaf, DJ VanBelzen, JM Jacobson, E Connick, ...
Journal of virology 92 (12), e00285-18, 2018
|Somatic HLA class I loss is a widespread mechanism of immune evasion which refines the use of tumor mutational burden as a biomarker of checkpoint inhibitor response|
M Montesion, K Murugesan, DX Jin, R Sharaf, N Sanchez, A Guria, ...
Cancer Discovery 11 (2), 282-292, 2021
|Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic|
EA Williams, S Santagata, H Wakimoto, GM Shankar, FG Barker, R Sharaf, ...
Acta neuropathologica communications 8 (1), 1-10, 2020
|HIV-1 balances the fitness costs and benefits of disrupting the host cell actin cytoskeleton early after mucosal transmission|
SM Usmani, TT Murooka, M Deruaz, WH Koh, RR Sharaf, M Di Pilato, ...
Cell host & microbe 25 (1), 73-86. e5, 2019
|Large syncytia in lymph nodes induced by CCR5-tropic HIV-1|
TT Murooka, RR Sharaf, TR Mempel
AIDS research and human retroviruses 31 (5), 471-472, 2015
|Visualizing the behavior of hiv-infected t cells in vivo using multiphoton intravital microscopy|
R Sharaf, TR Mempel, TT Murooka
HIV Protocols, 189-201, 2016
|Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations|
EA Williams, M Montesion, N Shah, R Sharaf, DC Pavlick, ES Sokol, ...
Modern Pathology 33 (12), 2397-2406, 2020
|Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles|
EA Williams, N Shah, M Montesion, R Sharaf, DC Pavlick, ES Sokol, ...
Modern Pathology 33 (8), 1466-1474, 2020
|CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinoma|
EA Williams, M Montesion, R Sharaf, J Corines, PJ Patel, BJ Gillespie, ...
Modern Pathology 33 (12), 2614-2625, 2020
|Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV–Forms Reveals Distinct Sets of Potentially Actionable Molecular Targets|
EA Williams, AJ Werth, R Sharaf, M Montesion, ES Sokol, DC Pavlick, ...
JCO Precision Oncology 4, 647-661, 2020
|Frequency of Post Treatment Control Varies by ART Restart and Viral Load Criteria.|
J Fajnzylber, R Sharaf, JN Hutchinson, E Aga, RJ Bosch, W Hartogensis, ...
AIDS (London, England), 2021
|CDKN2C-Null Leiomyosarcoma: A Novel, Genomically Distinct Class of TP53/RB1–Wild-Type Tumor With Frequent CIC Genomic Alterations and 1p/19q …|
EA Williams, R Sharaf, B Decker, AJ Werth, H Toma, M Montesion, ...
JCO Precision Oncology 4, 955-971, 2020